Prosecution Insights
Prosecution Insights
6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (50%) |
| §112 only | 1 (17%) |
| No statute on record | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAGHIGHATIAN, MINA | 1 | 45.8% | +40.0% |
| BOECKER, JOSEPH D | 1 | 83.4% | +23.0% |
| DITMER, KATHRYN ELIZABETH | 1 | 57.9% | +49.3% |
| MOK, ANDREW JUN-WAI | 1 | 50.7% | +70.4% |
| WOODWARD, VALERIE LYNN | 1 | 71.2% | +27.1% |
| GHALI, ISIS A D | 1 | 27.7% | +41.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17612132 | Removable Film-Forming Gel Compositions Featuring Adhesion Promoters | GHALI, ISIS A D | 50d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18599422 | METERED DOSE INHALERS AND SUSPENSION COMPOSITIONS | BOECKER, JOSEPH D | 167d overdue |
| 18025491 | APPARATUS FOR AGITATION OF MEDICAMENT FORMULATION | DITMER, KATHRYN ELIZABETH | 147d overdue |
| 17921774 | ADHESIVE ARTICLE AND METHOD OF MAKING SAME | MOK, ANDREW JUN-WAI | 49d overdue |
| 18606272 | FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION | HAGHIGHATIAN, MINA | 5d overdue |
| 17802431 | INHALER | WOODWARD, VALERIE LYNN | 27d |
| 17612132 | Removable Film-Forming Gel Compositions Featuring Adhesion Promoters | GHALI, ISIS A D | 50d |
| Art Unit | Apps |
|---|---|
| 3785 | 3 |
| 1616 | 1 |
| 3786 | 1 |
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18606272 | FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION | HAGHIGHATIAN, MINA | 1616 | §103 | Non-Final OA | 5d overdue | Pending | Mar 15, 2024 |
| 18599422 | METERED DOSE INHALERS AND SUSPENSION COMPOSITIONS | BOECKER, JOSEPH D | 3785 | — | Final Rejection | 167d overdue | Pending | Mar 08, 2024 |
| 18025491 | APPARATUS FOR AGITATION OF MEDICAMENT FORMULATION | DITMER, KATHRYN ELIZABETH | 3785 | §112 | Non-Final OA | 147d overdue | Pending | Mar 09, 2023 |
| 17921774 | ADHESIVE ARTICLE AND METHOD OF MAKING SAME | MOK, ANDREW JUN-WAI | 3786 | §103 | Non-Final OA | 49d overdue | Pending | Oct 27, 2022 |
| 17802431 | INHALER | WOODWARD, VALERIE LYNN | 3785 | §103 | Non-Final OA | 27d | Pending | Aug 25, 2022 |
| 17612132 | Removable Film-Forming Gel Compositions Featuring Adhesion Promoters | GHALI, ISIS A D | 1611 | Other | Non-Final OA | 50d | Pending | Nov 17, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial